Youngsuk Park

Clinical Professor

  • 10206 Citations
  • 46 h-Index
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Youngsuk Park is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer

Hong, J. Y., An, J. Y., Lee, J., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Kim, K. M., Kang, W. K. & Kim, S. T., 1 May 2020, In : Translational Cancer Research. 9, 5, p. 3367-3374 8 p.

Research output: Contribution to journalArticle

Open Access
  • Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer

    Yoo, G. S., Park, H. C., Yu, J. I., Choi, D. H., Cho, W. K., Park, Y. S., Park, J. O., Lim, H. Y., Kang, W. K., Lee, W. Y., Kim, H. C., Yun, S. H., Cho, Y. B., Park, Y. A., Song, K. D., Kim, S. H. & Ha, S. Y., 1 Apr 2020, In : Cancer research and treatment : official journal of Korean Cancer Association. 52, 2, p. 446-454 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study

    Byeon, S., Hong, J. Y., Lee, J., Nam, D. H., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Kang, W. K. & Kim, S. T., 1 Apr 2020, In : Targeted Oncology. 15, 2, p. 185-192 8 p.

    Research output: Contribution to journalArticle

  • TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer

    Hong, J. Y., Kim, H. J., Kim, K., Hong, J., Kim, J. E., Byeon, S. J., Lee, I. K., Kim, K. M., Shim, M., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Kim, S. T., Lee, J. & Kang, W. K., Mar 2020, In : Pathology Research and Practice. 216, 3, 152820.

    Research output: Contribution to journalArticle

  • Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study

    Kim, S. T., Hong, J. Y., Lee, J., Park, J. O., Lim, H. Y., Kang, W. K. & Park, Y. S., 1 Feb 2020, In : Targeted Oncology. 15, 1, p. 67-73 7 p.

    Research output: Contribution to journalArticle